ImmunityBio, Inc. — Director's Dealing 2016

Dec 3, 2016

SEC Form 4/A — Form 4/A

Issuer: NantKwest, Inc. (NK)
CIK: 0001326110
Period of Report: 2016-11-22

Reporting Person: Thomas John C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-11-23	Common Stock	S	7719	$7.50	Disposed	315070	Direct

Footnotes

F1: This amendment is filed to include 719 shares sold by the reporting person on November 23, 2016. These 719 shares were incorrectly included in the amount of shares beneficially owned by the reporting person in a subsequent Form 4 filed November 29, 2016.